Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumorsGeorge Mellgard, Che‐Kai Tsao, Parissa Alerasool et al.|Journal of Cancer Research and Clinical Oncology|2022Cited by 23
Type, timing, and patient characteristics associated with immune-related adverse event development in patients with advanced solid tumors treated with immune checkpoint inhibitors.Qian Qin, Che‐Kai Tsao, Vaibhav G. Patel et al.|Journal of Clinical Oncology|2020Cited by 16
Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysisQian Qin, Che‐Kai Tsao, Tomi Jun et al.|Discover Oncology|2022Cited by 12
Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor TherapyAnish B. Parikh, Che‐Kai Tsao, Xiaobo Zhong et al.|American Journal of Clinical Oncology|2021Cited by 4
Smoking status and immunotherapy outcomes in smoking-associated cancers.Tomi Jun, Che‐Kai Tsao, Teja Ganta et al.|Journal of Clinical Oncology|2020Cited by 3